Centre Hospitalier Universitaire de Nîmes

corporate_fareorganization

Web page: http://www.chu-nimes.fr/

Country: France

Wikidata: Q30253905

ISNI: 0000000405938241

ROR: https://ror.org/0275ye937

FundRef: 501100022656

Centre Hospitalier Universitaire de Nîmes

- Funding / Projects
  (27)

27 Projects, page 1 of 6

Social vulnerability and breast cancer
assignment_turned_inProject2011 - 2014Partners:Centre Hospitalier Universitaire de Nîmes, ICM-VAL D'AURELLE, IURC Institut Universitaire de Recherche Clinique, Centre de Recherche Franco-Québécois en Evaluation de Pratiques d'Interventions Sociales
Centre Hospitalier Universitaire de Nîmes,
ICM-VAL D'AURELLE,
IURC Institut Universitaire de Recherche Clinique,
Centre de Recherche Franco-Québécois en Evaluation de Pratiques d'Interventions Sociales
Funder: Institut National du Cancer Project Code: INCa-4688
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
IBRAA (Inflamed Brain Response in Alcohol Addiction: Understanding the role of neuroinflammation, immunotypes and gut-brain reactivity for heterogeneity in disease course and therapy response)
assignment_turned_inProjectFrom 2024Partners:ASOCIATIA TRANSYLVANIAN INSTITUTE OF NEUROSCIENCE, Spanish Superior Research Council, UCL, Centre Hospitalier Universitaire de Nîmes, Nutrition et Neurobiologie intégrée +1 partners
ASOCIATIA TRANSYLVANIAN INSTITUTE OF NEUROSCIENCE,
Spanish Superior Research Council,
UCL,
Centre Hospitalier Universitaire de Nîmes,
Nutrition et Neurobiologie intégrée,
Institute of Psychopharmacology at Central Institute for Mental Health
Funder: French National Research Agency (ANR) Project Code: ANR-23-NEU2-0005
Funder Contribution: 420,584 EUR
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Phase II/III randomised multicentre trial using a factorial design evaluating the advantage (i) of a strategy of primary surgery vs primary chemotherapy and (ii) chemotherapy with XELOX vs ECF in resectable gastric signet ring cell adenocarcinomas.
assignment_turned_inProjectPartners:HCL, Hôpital de la Croix-Rousse, Hôpital Beaujon, Hôpital Saint-Antoine, Hôpital Purpan +25 partners
HCL,
Hôpital de la Croix-Rousse,
Hôpital Beaujon,
Hôpital Saint-Antoine,
Hôpital Purpan,
Université de Lille III (Charles-de-Gaulle),
Groupe Hospitalier Henri Mondor - Albert Chenevier,
Hôpital Louis Mourier,
CHU Marseille - Hôpital la Timone,
Centre Hospitalier Universitaire de Nîmes,
Hôpital Tenon,
Centre Hospitalier Universitaire de Rennes,
HUS,
Hôpital Trousseau,
Hôpital Édouard Herriot,
Centre Hospitalier Universitaire d'Angers,
Hôpital Avicenne,
Centre Georges-François Leclerc,
Centre Léon Bérard,
Hôpital Ambroise Paré,
Institut Paoli-Calmettes- (IPC),
Institut Gustave Roussy,
Hôpital Européen Georges Pompidou (HEGP) - AP-,
Hôpital le Bocage,
Hôpital Claude Huriez,
Hôpital Charles-Nicolle,
Groupe Hospitalier Lariboisière - Fernand Widal,
Hôpital Hôtel-Dieu,
Hôpital Robert Debré,
Hôpital Haut-Lévêque
Funder: Institut National du Cancer Project Code: INCa-DGOS-3768
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
SHAPE 01 trial : A randomized phase III trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low-risk early-stage (LRES) cervical cancer
assignment_turned_inProjectPartners:Institut Paoli-Calmettes- (IPC), Centre Jean Perrin, Centre Hospitalier Universitaire Dijon Bourgogne, Centre Hospitalier Universitaire de Nîmes, Hôpital Tenon +22 partners
Institut Paoli-Calmettes- (IPC),
Centre Jean Perrin,
Centre Hospitalier Universitaire Dijon Bourgogne,
Centre Hospitalier Universitaire de Nîmes,
Hôpital Tenon,
Hôpital Européen Georges Pompidou (HEGP) - AP-HP,
Centre Léon Bérard,
ICM-VAL D'AURELLE,
Centre Oscar Lambret,
Hôpital Hôtel-Dieu,
Institut Bergonié,
Centre Georges-François Leclerc,
Clinique de l'Espérance,
Hôpital Pellegrin,
Centre René Gauducheau,
Hôpital Jeanne de Flandre,
Polyclinique de Courlancy,
Centre Hospitalier Universitaire de Limoges,
Institut de Cancérologie de Lorraine,
Groupe Hospitalier Lariboisière - Fernand Widal,
Hôpital Sud Anne de Bretagne,
Centre Hospitalier Universitaire de Nice,
CHU Reims - Hôpital de la Maison Blanche,
Centre Hospitalier Universitaire d'Angers,
Centre Henri Becquerel,
Institut Claudius Regaud,
CHUAP
Funder: Institut National du Cancer Project Code: INCa-DGOS-7161
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Search for a multi-gene signature to secure fluoropyrimidine-based chemotherapies in colorectal cancer patients
assignment_turned_inProjectUntil 2021Partners:INSERM U1251- Centre de génétique médicale de Marseille (MMG), Centre Hospitalier Universitaire de Nîmes, Centre Antoine Lacassagne, Institut Gustave Roussy
INSERM U1251- Centre de génétique médicale de Marseille (MMG),
Centre Hospitalier Universitaire de Nîmes,
Centre Antoine Lacassagne,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-13255
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Centre Hospitalier Universitaire de Nîmes

Centre Hospitalier Universitaire de Nîmes

Funder

27 Projects, page 1 of 6

Social vulnerability and breast cancer

IBRAA (Inflamed Brain Response in Alcohol Addiction: Understanding the role of neuroinflammation, immunotypes and gut-brain reactivity for heterogeneity in disease course and therapy response)

Phase II/III randomised multicentre trial using a factorial design evaluating the advantage (i) of a strategy of primary surgery vs primary chemotherapy and (ii) chemotherapy with XELOX vs ECF in resectable gastric signet ring cell adenocarcinomas.

SHAPE 01 trial : A randomized phase III trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low-risk early-stage (LRES) cervical cancer

Search for a multi-gene signature to secure fluoropyrimidine-based chemotherapies in colorectal cancer patients

Loading